Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy Study of Tenalisib (RP6530) in Combination With Pembrolizumab in Relapsed or Refractory cHL

Rhizen Pharmaceuticals SA · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
pembrolizumab
classical hodgkin lymphoma, hodgkin lymphoma, rp6530, pembrolizumab, tenalisib, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 916371
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.